Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;28(7):1012-1014.
doi: 10.1016/j.jiac.2022.03.009. Epub 2022 Mar 25.

Does the timing of saliva collection affect the diagnosis of SARS-CoV-2 infection?

Affiliations

Does the timing of saliva collection affect the diagnosis of SARS-CoV-2 infection?

Yuki Katayama et al. J Infect Chemother. 2022 Jul.

Abstract

We evaluated the optimal timing of saliva sample collection to diagnose the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We obtained 150 saliva samples at four specific time points from 13 patients with confirmed SARS-CoV-2 infection. The time points were (1) early morning (immediately after waking), (2) immediately after breakfast before tooth brushing, (3) 2 h after breakfast, and (4) before lunch. On the 2nd hospital day, patients collected saliva at the four time points by themselves. We collected samples at two time points, (1) and (3), from the 3rd hospital day to day 9 following symptom onset. In 52 samples collected at the four time points, there was no significant difference. Meanwhile, there was no significant difference in the positive proportion or the viral load between the two time points in both analyses by the day from symptom onset and by all samples. In this study, there was no difference in the positive proportions in saliva collected at various time points within 9 days after symptom onset. The timing of saliva collection was not affected by the diagnosis of SARS-CoV-2 infection.

Keywords: Collection timing; SARS-CoV-2; Saliva.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following conflict of interests which may be considered as potential competing interests: Satoshi Takahashi received speaker honoraria from MSD K.K. and research grants from Shino-Test Corporation, Roche Diagnostic K. K., Fujirebio Inc., and Abbott Japan Co., Ltd. All other authors declare no conflict of interests.

Figures

Fig. 1
Fig. 1
Transition of positive proportions in the SARS-CoV-2 molecular test for each day after symptom onset. White bar (□) shows positive proportion of SARS-CoV-2 molecular test in the early morning, gray bar (■) shows one at 2 h after breakfast.
Fig. 2
Fig. 2
SARS-CoV-2 viral loads at two time points. White bar (□) shows positive proportion of SARS-CoV-2 molecular test in the early morning, gray bar (■) shows one at 2 h after breakfast.

Similar articles

Cited by

References

    1. Chan J.F., Kok K.H., Zhu Z., Chu H., To K.K., Yuan S., et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microb Infect. 2020;9:221–236. doi: 10.1080/22221751.2020.1719902. - DOI - PMC - PubMed
    1. Uwamino Y., Nagata M., Aoki W., Fujimori Y., Nakagawa T., Yokota H., et al. Accuracy and stability of saliva as a sample for reverse transcription PCR detection of SARS-CoV-2. J Clin Pathol. 2021;74:67–68. doi: 10.1136/jclinpath-2020-206972. - DOI - PubMed
    1. Ministry of Health labor and Welfare. COVID-19 tests. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000121431_00182.html
    1. Yokota I., Shane P.Y., Okada K., Unoki Y., Yang Y., Inao T., et al. Mass screening of asymptomatic persons for severe acute respiratory syndrome coronavirus 2 using saliva. Clin Infect Dis. 2021;73:e559–e565. doi: 10.1093/cid/ciaa1388. - DOI - PMC - PubMed
    1. Hung D.L., Li X., Chiu K.H., Yip C.C., To K.K., Chan J.F., et al. Early-morning vs spot posterior oropharyngeal saliva for diagnosis of SARS-CoV-2 infection: implication of timing of specimen collection for community-wide screening. Open Forum Infect Dis. 2020;7 doi: 10.1093/ofid/ofaa210. ofaa210. - DOI - PMC - PubMed